Orchid Pharma releases Business Responsibility and Sustainability Report for FY25-26

Orchid Pharma releases Business Responsibility and Sustainability Report for FY25-26. The filing outlines the company’s ESG initiatives and corporate sustainability goals. No financial figures or strategic shifts were disclosed. This is a routine regulatory update under listing norms.
📊 STOCKS: ORCHIDPHARMA | 🏢 SECTOR: Pharma | #LOWIMPACT #Sustainability